Frenag Plus Spray

Frenag Plus Spray is a topical nonsteroidal anti-inflammatory drug (NSAID) combined with a local anesthetic, manufactured by Helba Pharmaceuticals in Turkey. This dual-action medication contains 1% nimesulide and 5% lidocaine, making it effective for localized pain management and inflammation reduction in various musculoskeletal conditions. The spray formulation allows for convenient application to affected areas without the need for direct contact, providing both analgesic and anti-inflammatory effects simultaneously. Understanding its composition, therapeutic applications, appropriate dosing, and potential side effects is essential for its safe and effective use.

Product Overview

Frenag Plus Spray belongs to the class of topical nonsteroidal anti-inflammatory drugs (NSAIDs) combined with local anesthetics. It is specifically formulated for external application to provide localized relief from pain and inflammation. The product is manufactured by Helba Ilaç Ve Dış San. Tic. Ltd. Şti, a Turkish pharmaceutical company specializing in topical pain relievers and anti-inflammatory medications.

The distinctive feature of this medication is its spray formulation, which allows for non-contact application to painful or sensitive areas. This makes it particularly suitable for treating conditions where touch might exacerbate discomfort or where application over larger areas is needed. The product is available in a 50 ml bottle equipped with a spray mechanism designed to deliver a precise dose with each application.

Classification and Availability

Frenag Plus Spray is classified under M02AA in the Anatomical Therapeutic Chemical (ATC) classification system, which categorizes it as a topical preparation for joint and muscular pain. The medication requires a prescription in Turkey and other countries where it is marketed. Its distinct yellow packaging and 50 ml bottle with spray applicator make it readily identifiable in pharmacy settings. The spray format distinguishes it from its sister product, Frenag Plus Gel, which contains the same active ingredients but in a different delivery system.

Composition and Formulation

Active Ingredients

Frenag Plus Spray contains two primary active ingredients that work synergistically to provide pain relief and reduce inflammation:

1. Nimesulide (1%): Each milliliter of solution contains 10 mg of nimesulide, with each spray delivering approximately 1 mg. Nimesulide is a nonsteroidal anti-inflammatory drug that works by inhibiting cyclooxygenase-2 (COX-2), an enzyme involved in inflammation processes. This selective inhibition helps to reduce inflammation, pain, and fever while potentially causing fewer gastrointestinal side effects compared to non-selective NSAIDs.

2. Lidocaine (5%): Each milliliter contains 50 mg of lidocaine (as lidocaine hydrochloride), with each spray delivering approximately 5 mg. Lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of pain signals. This provides a rapid onset of pain relief while the anti-inflammatory effects of nimesulide develop.

Inactive Ingredients

The formulation includes several excipients that enhance stability, absorption, and sensory experience:

• Polyethylene glycol 400: Serves as a solvent and enhances skin penetration

• Hydroxypropyl cellulose: Acts as a thickening agent and stabilizer

• Menthol: Provides a cooling sensation and mild local anesthetic effect

• Ethanol: Functions as a solvent and penetration enhancer

• Lactic acid: Helps maintain pH balance

• Sodium hydroxide: Used for pH adjustment

• Purified water: Serves as the vehicle for the solution

This combination creates a stable, fast-drying solution that penetrates effectively through the skin barrier to deliver the active ingredients to the affected tissues.

Therapeutic Uses

Frenag Plus Spray is indicated for the local treatment of various musculoskeletal conditions characterized by pain, inflammation, and muscle tension. Its dual-action formula makes it particularly effective for conditions requiring both analgesic and anti-inflammatory effects. The spray demonstrates efficacy in treating the following conditions:

Rheumatic Conditions

The medication is effective in managing various rheumatic disorders including osteoarthritis (joint degeneration), rheumatoid arthritis (autoimmune joint inflammation), periarthritis (inflammation of tissues surrounding joints), tendinitis (inflammation of tendons), tenosynovitis (inflammation of the sheath that surrounds a tendon), and bursitis (inflammation of the fluid-filled sacs that cushion joints). These conditions are characterized by varying degrees of pain, swelling, and restricted movement, which the active ingredients in Frenag Plus Spray specifically target.

Sports Injuries and Trauma

Frenag Plus Spray is also indicated for the symptomatic relief of pain and inflammation associated with sports injuries, including sprains, strains, contusions, and minor traumas to soft tissues and joints. The rapid absorption of the medication provides quick relief from acute pain while simultaneously addressing the underlying inflammatory process. This makes it suitable for both immediate post-injury management and ongoing treatment during recovery phases.

Musculoskeletal Pain

The product is effective for managing localized musculoskeletal pain, including back pain (lumbago) and muscle tension. The combination of nimesulide’s anti-inflammatory action and lidocaine’s anesthetic effect provides comprehensive relief from both the pain sensation and the underlying inflammatory causes. This dual mechanism ensures more complete and longer-lasting relief than single-action products.

Administration and Dosage

Method of Application

Frenag Plus Spray is designed for topical application directly to the affected area of the skin. The spray formulation allows for a non-contact application, which is particularly advantageous for sensitive or painful areas. Before application, the affected area should be clean and dry. The bottle should be held approximately 10-15 cm away from the skin, and the spray should be applied in short bursts rather than a continuous stream. After application, allow the solution to dry naturally without covering the area with bandages or occlusive dressings, as this could increase systemic absorption of the active ingredients.

Recommended Dosage

The standard recommended dosage is 4-5 spray applications to the affected area, 3-4 times daily, or as directed by a healthcare professional. Each spray delivers approximately 1 mg of nimesulide and 5 mg of lidocaine. The total daily dose should not exceed 20 sprays per affected area. Treatment duration typically ranges from 7 to 14 days, depending on the condition being treated and the patient’s response. Extended use beyond two weeks should occur only under medical supervision due to potential risks associated with prolonged NSAID use.

Special Application Instructions

It is important to avoid applying the spray to broken, damaged, or irritated skin. The spray should not come into contact with eyes, mucous membranes, or open wounds. If accidental contact occurs, rinse thoroughly with water. Patients should wash their hands after application unless the hands are the area being treated. The medication should not be applied simultaneously with other topical products on the same area. After application, avoid covering the area with bandages or occlusive dressings, as this could increase the risk of side effects due to enhanced absorption.

Precautions and Contraindications

Contraindications

Frenag Plus Spray is contraindicated in several situations to avoid adverse reactions. Patients with known hypersensitivity to nimesulide, lidocaine, or any of the excipients should not use this medication. Additionally, individuals who have experienced asthma attacks, urticaria, or other allergic reactions after taking acetylsalicylic acid (aspirin) or other NSAIDs should avoid using this product due to the risk of cross-sensitivity. The spray should not be used on open wounds, infected areas, or mucous membranes. Patients with severe hepatic or renal impairment should also avoid using this medication due to potential systemic absorption and increased risk of adverse effects.

Precautions During Use

When using Frenag Plus Spray, certain precautions should be observed to ensure safety and efficacy. The spray should not be applied to large areas of the body exceeding 10% of the total body surface area. Prolonged use should be avoided without medical supervision, as extended use of topical NSAIDs may increase the risk of sensitization and local adverse reactions. Contact with clothing should be minimized as the spray may cause staining, though this is typically removable with washing. Patients should avoid using other topical medications concurrently on the same area unless prescribed by a healthcare professional.

Special Population Considerations

Pregnant women should not use Frenag Plus Spray during the first or third trimester due to potential risks to the fetus associated with NSAID use. Use during the second trimester should occur only if clearly necessary and under medical supervision. Nursing mothers should use caution as it is not known whether the active ingredients are excreted in breast milk. The safety and efficacy in children have not been established, so the product is not recommended for pediatric use. Elderly patients may be more susceptible to side effects and should use the minimum effective dose under close supervision.

Side Effects

Common Side Effects

While Frenag Plus Spray is generally well-tolerated when used as directed, some patients may experience mild local reactions at the application site. These reactions include temporary skin irritation, redness (erythema), and itching (pruritus). These effects are typically mild and transient, resolving spontaneously without requiring discontinuation of treatment. Some patients may also experience a cooling or tingling sensation due to the menthol content, which is considered a normal part of the product’s action rather than an adverse effect.

Uncommon Side Effects

Less frequently, users may experience allergic contact dermatitis, characterized by more pronounced redness, itching, and the development of small vesicles or papules. Some patients may report a burning sensation upon application, particularly if the skin is compromised or sensitive. In rare cases, photosensitivity reactions (increased sensitivity to sunlight) may occur in treated areas, so patients should avoid extensive sun exposure or use appropriate sun protection on treated areas.

Rare but Serious Side Effects

Though uncommon due to the topical nature of the product and limited systemic absorption, serious adverse reactions can occur, particularly with improper use or use over extensive areas. These include severe allergic reactions such as facial, lip, tongue, or throat swelling; difficulty breathing; severe skin rashes; and cardiovascular collapse. Lidocaine, especially when applied to large skin surfaces or under occlusive dressings, can potentially cause cardiac arrhythmias, breathing difficulties, coma, and even death, though this risk is minimal with proper use of the spray formulation.

Drug Interactions

Topical Drug Interactions

Concurrent application of other topical medications on the same area as Frenag Plus Spray should be avoided to prevent potential interactions or altered absorption of either product. Particular caution should be exercised with other products containing local anesthetics, as this could lead to additive effects and increased risk of systemic toxicity. Similarly, concurrent use with other topical NSAIDs could enhance both therapeutic effects and potential side effects.

Systemic Drug Interactions

Though systemic absorption of topically applied nimesulide and lidocaine is limited, some caution is warranted regarding potential interactions with systemic medications. Patients taking oral anticoagulants, anti-platelet agents, or other NSAIDs should use Frenag Plus Spray cautiously, as any systemically absorbed nimesulide could theoretically enhance the effects of these medications. Similarly, patients taking Class I antiarrhythmic drugs (similar to lidocaine) should use the spray with caution due to potential additive effects if significant systemic absorption occurs.

Storage and Handling

Frenag Plus Spray should be stored at room temperature, preferably between 15-25°C (59-77°F), in a dry place away from direct sunlight and heat sources. The bottle should be kept tightly closed when not in use to prevent evaporation of the volatile components. As with all medications, it should be stored out of reach of children. The product should not be used beyond the expiration date printed on the package. If the appearance or odor of the solution changes, the product should not be used. Empty bottles should be disposed of according to local regulations for pharmaceutical waste.

Table of Key Information

Conclusion

Frenag Plus Spray represents an effective topical therapy for various musculoskeletal conditions characterized by pain and inflammation. Its unique formulation combining nimesulide and lidocaine provides dual action – anti-inflammatory effects and rapid pain relief through local anesthesia. The spray delivery system offers convenient, non-contact application particularly beneficial for sensitive or painful areas.

While generally well-tolerated when used appropriately, users should be aware of potential side effects and contraindications. As with any medication, consultation with a healthcare professional is recommended before initiating treatment, especially for patients with pre-existing medical conditions or those taking other medications. When used according to guidelines, Frenag Plus Spray can be a valuable tool in managing localized pain and inflammation, improving mobility and quality of life for those suffering from various musculoskeletal disorders.